At-Home Drug of Abuse (DOA) Testing Market - Growth, Trends, and Forecasts (2022 - 2027)

At-Home Drug of Abuse (DOA) Testing Market - Growth, Trends, and Forecasts (2022 - 2027)

The surge in the number of people who consume alcohol and illicit drugs such as marijuana, cocaine, and others, is one of the major drivers for market growth. Developed countries such as the United States have stringent laws for drug abuse and have mandated alcohol and drug testing to take legal action against addicts and abusers for the sake of limiting violence or accidents. Furthermore, the increasing overdose of prescription drugs and the diagnosis of these drugs and their metabolites is boosting the at-home drug of abuse testing market. According to the National Survey on Drug Use and Health (NSDUH), 19.7 million American adults engaged in a substance use disorder in 2017. However, lack of awareness of these testing devices is a constraint to the market growth.

Key Market TrendsAnalysis of Urine is Expected to be the Dominant Segment by Sample Type Over the Forecast Period.

The dominant share of the segment is attributed to the advantages of drug of abuse testing using a urine sample. Detection through urine sample is the easiest and most affordable way, both illegal and prescription drugs can be checked for. The major advantage of the test is that the analysis can determine if specific drugs are used in the past few days or weeks, even after the effects of the drugs have worn off. Apart from the advantages the increasing drug consumption and increasing need to check the drug levels at home is boosting the segment growth. In 2018, there were an estimated 34.1 million young adults who suffered from both a mental health disorder and a substance use disorder or co-occurring disorders as per American Addiction Center. With this huge number of people suffering the segment and the market is tend to grow at a higher rate in the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The dominant position of the market in this region is mainly due to a high number of people who are suffering from substance abuse or alcohol addiction. According to American Addiction Centers almost 74% of adults suffering from a substance use disorder in 2017 struggled with an alcohol use disorder. About 38% of adults in 2017 battled an illicit drug use disorder and 1 out of every 8 adults struggled with both alcohol and drug use disorders simultaneously. The high contribution due to the adaptation of technologically advanced products for drug abuse testing, increased demand for illicit drugs in the region, large scale drug trafficking, that is being responsible for the growth of the market.

Competitive Landscape

The At-Home Drug of Abuse (DOA) Testing Market is moderately competitive with several major players. Some of the major players are Abbott, Dragerwerk AG & Co. KGaA, UCP Biosciences Inc., Orient New Life Medical Co. Ltd., Assure Tech.(Hangzhou) Co., LTD, Psychemedics Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned
 
Abbott
Dragerwerk AG & Co. KGaA
UCP Biosciences Inc.
Orient New Life Medical Co. Ltd.
Assure Tech.(Hangzhou) Co., LTD
Psychemedics Corporation
CONFIRM BIOSCIENCES
Phamatech Inc.
Home Health (UK) Ltd

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.